Semax 50mg 20ml Nasal Spray
AUD $349
For laboratory research use only. Not for human use.
Research-grade Semax in a convenient 20ml nasal spray format. 50mg total peptide content. Third-party HPLC tested to ≥98% purity. Supplied with Certificate of Analysis. For laboratory research use only.
Supply Specifications
| Peptide | Semax (Met-Glu-His-Phe-Pro-Gly-Pro) |
| Format | Nasal spray, 20ml |
| Total content | 50mg |
| Purity | ≥98% by HPLC |
| Testing | Third-party HPLC + Mass Spec |
| Storage | 2–8°C, protect from light |
| Use | Laboratory research use only |
| Price | AUD $349 |
Research Summary
Semax is a synthetic heptapeptide derived from the ACTH 4-10 fragment. It has been studied in preclinical models for its apparent effects on BDNF (brain-derived neurotrophic factor) expression, cognitive function, and neuroprotection.
The nasal spray format has been studied for its potential to deliver Semax via the olfactory pathway, which may allow direct access to the central nervous system. Preclinical studies in rodent models have observed apparent CNS activity following intranasal Semax administration.
Semax is used in clinical practice in Russia and Ukraine for neurological conditions, though it is not TGA-approved in Australia. Available for laboratory research use only.
Related Research
Disclaimer: All products supplied by PeptideIQ are for laboratory research use only. They are not approved for human use, consumption, or therapeutic application. PeptideIQ complies with all applicable Australian regulations including the Therapeutic Goods Act 1989.